Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, January 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 415 articles:
HTML format


 

Single Articles

  1. SHI J, Dong Y, Jiang W, Qin F, et al
    MRI-based peritumoral radiomics analysis for preoperative prediction of lymph node metastasis in early-stage cervical cancer: A multi-center study.
    Magn Reson Imaging. 2021 Dec 27. pii: S0730-725X(21)00256.
    PubMed    
    Abstract available

  2. RANGOLO N, Tshitangano TG, Olaniyi FC
    Compliance of Professional Nurses at Primary Health Care Facilities to the South African Cervical Cancer Screening Guidelines.
    Nurs Rep. 2021;11:741-749.
    PubMed    
    Abstract available

  3. HARI AY, Bernstein M, Temko J, Brabender DE, et al
    Risk factors for cervical cancer among distinct populations in low-resource countries: feasibility of cervical cancer screen-and-treat program on ukerewe island of lake victoria, Tanzania.
    Curr Opin Obstet Gynecol. 2022;34:20-27.
    PubMed    
    Abstract available

  4. KUGELMAN N, Siegler E, Mackuli L, Lavie O, et al
    Prognosis of Human Papillomavirus-Negative Compared to Human Papillomavirus-Positive Cervical Cancer.
    J Low Genit Tract Dis. 2021 Dec 28. pii: 00128360-900000000-99324.
    PubMed    
    Abstract available

  5. JONES SR, Vidrine DJ, Wetter DW, Shih YT, et al
    Evaluation of the Efficacy of a Smoking Cessation Intervention for Cervical Cancer Survivors and Women With High-Grade Cervical Dysplasia: Protocol for a Randomized Controlled Trial.
    JMIR Res Protoc. 2021;10:e34502.
    PubMed    
    Abstract available

  6. FAHMI MN, Hertapanndika IN, Kusuma F
    The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2021;22:4057-4065.
    PubMed    
    Abstract available

  7. GOLOVKO TS, Bakai OA, Ashykhmin AV, Baranovskaya LM, et al
    Comparison of ultrasound and MRI informativeness for detection and treatment monitoring of cervical cancer metastases in the vagina.
    Exp Oncol. 2021;43:351-358.
    PubMed    
    Abstract available

  8. LEE KP, Baek S, Yoon MS, Park JS, et al
    Potential anticancer effect of aspirin and 2'-hydroxy-2,3,5'-trimethoxychalcone-linked polymeric micelles against cervical cancer through apoptosis.
    Oncol Lett. 2022;23:31.
    PubMed    
    Abstract available

  9. BEEKMAN C, van Beek S, Stam J, Sonke JJ, et al
    Improving predictive CTV segmentation on CT and CBCT for cervical cancer by diffeomorphic registration of a prior.
    Med Phys. 2021 Dec 29. doi: 10.1002/mp.15421.
    PubMed    
    Abstract available

  10. LIU Y, Li Y, Yu L, Yang Z, et al
    Monocomponent Nanodots with Dichromatic Output Regulated by Synergistic Dual-Stimuli for Cervical Cancer Tissue Imaging and Photodynamic Tumor Therapy.
    Anal Chem. 2021 Dec 28. doi: 10.1021/acs.analchem.1c03488.
    PubMed    
    Abstract available

  11. LIN S, Chen WT, Gu C, Cheng HL, et al
    Knowledge, perception of HIV symptom severity and cervical cancer screening behaviour among women living with HIV in China.
    Eur J Cancer Care (Engl). 2021 Dec 27:e13542. doi: 10.1111/ecc.13542.
    PubMed    
    Abstract available

  12. CAROBELI LR, Meirelles LEF, Damke GMZF, Damke E, et al
    Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy.
    Pharmaceutics. 2021;13.
    PubMed    
    Abstract available

  13. CURTI RRJ, Castilha EP, Bonaldo ALL, Okuyama NCM, et al
    Development of cervical intraepithelial lesions and cervical cancer is not influenced by SOD2 RS4880 polymorhism.
    Pathol Res Pract. 2021;230:153742.
    PubMed    
    Abstract available

  14. LAKOMY DS, Wu J, Chapman BV, Yu ZH, et al
    Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer.
    Pract Radiat Oncol. 2021 Dec 24. pii: S1879-8500(21)00351.
    PubMed    
    Abstract available

  15. GOH Y, Kim D, Kim JY, Kim HS, et al
    Active small bowel sparing in intracavitary brachytherapy for cervical cancer.
    Jpn J Clin Oncol. 2021 Dec 27. pii: 6484511. doi: 10.1093.
    PubMed    
    Abstract available

  16. LOVREC VG, Arko D, Takac I
    Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor.
    Radiol Oncol. 2021 Dec 22. pii: raon-2021-0054. doi: 10.2478/raon-2021-0054.
    PubMed    
    Abstract available

  17. LU Y, Chen Y, Zhang Z, Li M, et al
    HPV16 E6 promotes cell proliferation, migration, and invasion of human cervical cancer cells by elevating both EMT and stemness characteristics.
    Cell Biol Int. 2021 Dec 26. doi: 10.1002/cbin.11756.
    PubMed    
    Abstract available

  18. BANUELOS-VILLEGAS EG, Perez-yPerez MF, Alvarez-Salas LM
    Cervical Cancer, Papillomavirus, and miRNA Dysfunction.
    Front Mol Biosci. 2021;8:758337.
    PubMed    
    Abstract available

  19. WEN LJ, Hu XL, Li CY, Liu J, et al
    Myosin 1b promotes migration, invasion and glycolysis in cervical cancer via ERK/HIF-1alpha pathway.
    Am J Transl Res. 2021;13:12536-12548.
    PubMed    
    Abstract available

  20. MA R, Yu R, Yuan Y, Ren B, et al
    Effects of Traditional Chinese Medicine for Vaginal Lavage Combined with Psychological Intervention in Postoperative Patients with Cervical Cancer.
    Evid Based Complement Alternat Med. 2021;2021:5751795.
    PubMed    
    Abstract available

  21. CHARGARI C, Peignaux K, Escande A, Renard S, et al
    Radiotherapy of cervical cancer.
    Cancer Radiother. 2021 Dec 17. pii: S1278-3218(21)00298.
    PubMed    
    Abstract available

  22. LI R, Liu J, Qi J
    Retraction notice to "Knockdown of long non-coding RNA CCAT1 suppresses proliferation and EMT of human cervical cancer cell lines by down-regulating Runx2" [Experimental and Molecular Pathology 113 (2020) 104380].
    Exp Mol Pathol. 2021 Dec 23:104736. doi: 10.1016/j.yexmp.2021.104736.
    PubMed    


  23. ISHIDA M, Hiraoka M, Yaguchi A, Sugano K, et al
    Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis.
    Palliat Support Care. 2021 Dec 27:1-3. doi: 10.1017/S1478951521001917.
    PubMed    
    Abstract available

  24. WU CH, Pei RX, Yan JX, Ding L, et al
    [The effect of red blood cell folate on the prognosis of high-risk human papillomavirus infection: a community-based cohort study].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42:2174-2178.
    PubMed    
    Abstract available

  25. WANG R, Zhang Y, Shan F
    PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer?
    Int Immunopharmacol. 2021;103:108484.
    PubMed    
    Abstract available

  26. WANG Y, Xie Y, Sun B, Guo Y, et al
    The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells.
    Infect Agent Cancer. 2021;16:71.
    PubMed    
    Abstract available

  27. MAHMOOD HA, Tomas Bort E, Walker AJ, Grose RP, et al
    FGF signalling facilitates cervical cancer progression.
    FEBS J. 2021 Dec 24. doi: 10.1111/febs.16331.
    PubMed    
    Abstract available

  28. HUANG Y, Chen S, Lei Y, Chung C, et al
    beta-Estradiol Induces Mitochondrial Apoptosis in Cervical Cancer Through the Suppression of AKT/NF-kappaB Signaling Pathway.
    Recent Pat Anticancer Drug Discov. 2021 Dec 22. pii: PRA-EPUB-119615.
    PubMed    
    Abstract available

  29. XU X, Han Z, Ruan Y, Liu M, et al
    HPV16-LINC00393 Integration Alters Local 3D Genome Architecture in Cervical Cancer Cells.
    Front Cell Infect Microbiol. 2021;11:785169.
    PubMed    
    Abstract available

  30. WANG M, Tian Y, Miao L, Zhao W, et al
    MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34).
    J Oncol. 2021;2021:2669822.
    PubMed    
    Abstract available

  31. DUZGUN O, Kalin M
    Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
    Clin Med Insights Oncol. 2021;15:11795549211065308.
    PubMed    
    Abstract available

  32. BOBER P, Firment P, Sabo J
    Diagnostic Test Accuracy of First-Void Urine Human Papillomaviruses for Presence Cervical HPV in Women: Systematic Review and Meta-Analysis.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  33. ADEGBOYEGA A, Wu JR, Mudd-Martin G
    Acculturation Strategies and Pap Screening Uptake among Sub-Saharan African Immigrants (SAIs).
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  34. WANG J, Lv F, Sun T, Zhao S, et al
    Sorafenib Nanomicelles Effectively Shrink Tumors by Vaginal Administration for Preoperative Chemotherapy of Cervical Cancer.
    Nanomaterials (Basel). 2021;11.
    PubMed    
    Abstract available

  35. AKKOUR K, Alghuson L, Benabdelkamel H, Alhalal H, et al
    Cervical Cancer and Human Papillomavirus Awareness among Women in Saudi Arabia.
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  36. MCDANIEL CC, Hallam HH, Cadwallader T, Lee HY, et al
    Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  37. VAN KOL K, Ebisch R, Piek J, Beugeling M, et al
    Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  38. QUIST KM, Solorzano I, Wendel SO, Chintala S, et al
    Cervical Cancer Development: Implications of HPV16 E6E7-NFX1-123 Regulated Genes.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  39. COLZANI E, Johansen K, Johnson H, Pastore Celentano L, et al
    Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma.
    Euro Surveill. 2021;26.
    PubMed    
    Abstract available

  40. FICK RHJ, Tayart B, Bertrand C, Lang SC, et al
    A Partial Label-Based Machine Learning Approach For Cervical Whole-Slide Image Classification: The Winning TissueNet Solution().
    Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:2127-2131.
    PubMed    
    Abstract available

  41. JEFFRIES A, Beck-Sague CM, Marroquin-Garcia AB, Dean M, et al
    Cervical Visual Inspection with Acetic Acid (VIA) and Oncogenic Human Papillomavirus Screening in Rural Indigenous Guatemalan Women: Time to Rethink VIA.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  42. WATANABE M, Hosono S, Nakagawa-Senda H, Yamamoto S, et al
    Does Direct-to-Consumer Personal Genetic Testing Improve Gynecological Cancer Screening Uptake among Never-Screened Attendees? A Randomized Controlled Study.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  43. LIN CY, Wang CC, Wu RC, Yang LY, et al
    Inhibition of BIRC2 Sensitizes alpha7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  44. JALALI-ALHOSSEINI P, Shoja Z, Soleimani-Jelodar R, Shokrallahnia-Roshan H, et al
    Lineage and sublineage analysis of human papillomavirus type 56 in cervical samples of Iranian women.
    J Med Virol. 2021;93:6412-6417.
    PubMed    
    Abstract available

  45. INTAHPHUAK S, Nambunmee K, Kuipiaphum P
    Factors Influence on Pap Test Screening among Lahu Hill Tribe Women in Remote Area Thailand.
    Asian Pac J Cancer Prev. 2021;22:2243-2249.
    PubMed    
    Abstract available

  46. SARMA U, Das GC, Sarmah B
    Predictive Value of Marker of Proliferation Ki-67 and Cell Cycle Dependent Protein kinase Inhibitor P16INK4a in Cervical Biopsy to Determine Its Biological Behaviour.
    Asian Pac J Cancer Prev. 2021;22:2237-2241.
    PubMed    
    Abstract available

  47. INTHASORN P, Wetpithayakom N, Laiwejpithaya S, Lohsiriwat V, et al
    Prevalence of Abnormal Anal Cytology in Women with Abnormal Cervical Cytology.
    Asian Pac J Cancer Prev. 2021;22:2165-2169.
    PubMed    
    Abstract available

  48. BHATI P, Thomas A, Sebastian A, Mani T, et al
    Diagnostic Accuracy of Fluorescein Sodium for Targeted Cervical Biopsies.
    Asian Pac J Cancer Prev. 2021;22:2135-2141.
    PubMed    
    Abstract available

  49. WANG X, Wu S, Li Y
    Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
    J Med Virol. 2021;93:6355-6361.
    PubMed    
    Abstract available

  50. RUIZ-LAFUENTE N, Minguela A, Muro M, Parrado A, et al
    The roles of Cdc42 and Rac1 in the formation of plasma membrane protrusions in cancer epithelial HeLa cells.
    Mol Biol Rep. 2021;48:4285-4294.
    PubMed    
    Abstract available

  51. ELIZABETH NB, Malik M, Valiyaveettil D, Basalathullah MAR, et al
    Outcomes in patients of carcinoma cervix Stage IIIB treated with definitive radiotherapy.
    Cancer Treat Res Commun. 2021;27:100365.
    PubMed    
    Abstract available

  52. MILLET P, Gauthier T, Vieillefosse S, Dewaele P, et al
    Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF).
    J Gynecol Obstet Hum Reprod. 2021;50:102134.
    PubMed    
    Abstract available

  53. BOTTARI F, Iacobone AD, Radice D, Preti EP, et al
    Anyplex II HPV test in detection and follow-up after surgical treatment of CIN2+ lesions.
    J Med Virol. 2021;93:6340-6346.
    PubMed    
    Abstract available

  54. AHN S, Kim GJ, Do SI, Kim K, et al
    High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis.
    J Epidemiol. 2021;31:615-620.
    PubMed    
    Abstract available

  55. LI PH, Chan SCW, Lau CS, Seto MTY, et al
    Conventional and Biologic Disease-Modifying Antirheumatic Drugs Are Not Associated With Increase in or Progression of Cervical Neoplasia Among Patients With Spondyloarthritis.
    J Clin Rheumatol. 2022;28:e63-e68.
    PubMed    
    Abstract available

  56. BIGAARD J, Franceschi S
    Vaccination against HPV: boosting coverage and tackling misinformation.
    Mol Oncol. 2021;15:770-778.
    PubMed    
    Abstract available

  57. TERASAWA T, Hosono S, Sasaki S, Hoshi K, et al
    Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis.
    Sci Rep. 2022;12:94.
    PubMed    
    Abstract available

  58. ESWARAN S, Adiga D, Khan G N, S S, et al
    Comprehensive Analysis of the Exocytosis Pathway Genes in Cervical Cancer.
    Am J Med Sci. 2022 Jan 4. pii: S0002-9629(21)00448.
    PubMed    
    Abstract available

  59. GAO F, Li P, Kong X, Song T, et al
    ARID1A-mutated cervical cancer depends on the activation of YAP signaling.
    Front Biosci (Landmark Ed). 2021;26:1411-1421.
    PubMed    
    Abstract available

  60. KAMIMA T, Ueda Y, Fukunaga JI, Tamura M, et al
    Knowledge-based planning using pseudo-structures for volumetric modulated arc therapy (VMAT) of postoperative uterine cervical cancer: a multi-institutional study.
    Rep Pract Oncol Radiother. 2021;26:849-860.
    PubMed    
    Abstract available

  61. JIANG Y, Gu H, Zheng X, Pan B, et al
    Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Pathol Oncol Res. 2021;27:1609946.
    PubMed    
    Abstract available

  62. MEKURIA M, Edosa K, Endashaw M, Bala ET, et al
    Prevalence of Cervical Cancer and Associated Factors Among Women Attended Cervical Cancer Screening Center at Gahandi Memorial Hospital, Ethiopia.
    Cancer Inform. 2021;20:11769351211068431.
    PubMed    
    Abstract available

  63. LOAEZA-LOAEZA J, Illades-Aguiar B, Del Moral-Hernandez O, Castro-Coronel Y, et al
    The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer.
    Clin Epigenetics. 2022;14:4.
    PubMed    
    Abstract available

  64. BAO H, Li X, Cao Z, Huang Z, et al
    Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification.
    J Transl Med. 2022;20:18.
    PubMed    
    Abstract available

  65. NAZNEEN F, Millat MS, Barek MA, Aziz MA, et al
    Genetic Polymorphism of miR-218-2 (rs11134527) in Cervical Cancer: A Case-Control Study on the Bangladeshi Women.
    Microrna. 2021;10:219-224.
    PubMed    
    Abstract available

  66. DWI NINGTIYAS W, Isnafia Arief I, Budiman C, Handoyo Utomo AR, et al
    Inhibition of Human Cervical Cancer Hela Cell Line by Meat-Derived Lactic Acid Bacteria of Lactobacillus plantarum IIA-1A5 and Lactobacillus acidophilus IIA-2B4.
    Pak J Biol Sci. 2021;24:1340-1349.
    PubMed    
    Abstract available

  67. ALIFU N, Ma R, Zhu L, Du Z, et al
    A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer.
    J Mater Chem B. 2022 Jan 6. doi: 10.1039/d1tb02481.
    PubMed    
    Abstract available

  68. FENG Q, Wang J, Cui N, Liu X, et al
    Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases.
    Ann Transl Med. 2021;9:1668.
    PubMed    
    Abstract available

  69. OKUNOWO AA, Ugwu AO, Kuku JO, Soibi-Harry AP, et al
    Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria.
    Prev Med Rep. 2021;24:101643.
    PubMed    
    Abstract available

  70. ZHANG Y, Ding J, Hua K
    Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
    J Int Med Res. 2022;50:3000605211067397.
    PubMed    
    Abstract available

  71. SADRI H, Aghaei M, Akbari V
    Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes.
    Biochem Cell Biol. 2022 Jan 5. doi: 10.1139/bcb-2021-0225.
    PubMed    
    Abstract available

  72. PHOOLCHAROEN N, Varon ML, Baker E, Parra S, et al
    Hands-On Training Courses for Cervical Cancer Screening, Diagnosis, and Treatment Procedures in Low- and Middle-Income Countries.
    JCO Glob Oncol. 2022;8:e2100214.
    PubMed    
    Abstract available

  73. LIU H, Liu L, Liu Q, He F, et al
    LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1.
    Cell Cycle. 2022 Jan 5:1-11. doi: 10.1080/15384101.2021.2020962.
    PubMed    
    Abstract available

  74. ZHANG Y, Zheng M, Zhang L, Yuan P, et al
    LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p /LYPLA1 Axis.
    Biochem Genet. 2022 Jan 4. pii: 10.1007/s10528-021-10182.
    PubMed    
    Abstract available

  75. BURROWES S, Holcombe SJ, Leshargie CT, Hernandez A, et al
    Perceptions of cervical cancer care among Ethiopian women and their providers: a qualitative study.
    Reprod Health. 2022;19:2.
    PubMed    
    Abstract available

  76. CHEN L, Dong J, Li Z, Chen Y, et al
    The B7H4-PDL1 classifier stratifies immuno-phenotype in cervical cancer.
    Cancer Cell Int. 2022;22:3.
    PubMed    
    Abstract available

  77. DE LA CRUZ-CONCEPCION B, Gutierrez-Escobar A, Lorenzo-Moran HY, Navarro-Tito N, et al
    Use of coumarins as complementary medicine with an integrative approach against cervical cancer: background and mechanisms of action.
    Eur Rev Med Pharmacol Sci. 2021;25:7654-7667.
    PubMed    
    Abstract available

  78. WANG Q, Xu B, Liu H, Wang D, et al
    CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR-153-3p/ATF2 axis and wnt/beta-catenin pathway.
    Drug Dev Res. 2022 Jan 3. doi: 10.1002/ddr.21908.
    PubMed    
    Abstract available

  79. HE T, Sun J, Wu J, Wang H, et al
    PET-CT versus MRI in the diagnosis of lymph node metastasis of cervical cancer: A meta-analysis.
    Microsc Res Tech. 2022 Jan 4. doi: 10.1002/jemt.24039.
    PubMed    
    Abstract available

  80. MILLET N, McDermott HJ, Munir F, Edwardson CL, et al
    ACCEPTANCE: protocol for a feasibility study of a multicomponent physical activity intervention following treatment for cervical cancer.
    BMJ Open. 2022;12:e048203.
    PubMed    
    Abstract available

  81. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez J, et al
    Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study.
    Brachytherapy. 2021 Dec 31. pii: S1538-4721(21)00532.
    PubMed    
    Abstract available

  82. QIN X, Zhang F, Hou X, Yu L, et al
    Efficacy and safety of a 3D-printed applicator for vaginal brachytherapy in patients with central pelvic-recurrent cervical cancer after primary hysterectomy.
    Brachytherapy. 2021 Dec 31. pii: S1538-4721(21)00533.
    PubMed    
    Abstract available

  83. SAPIENZA LG, Ludwig MS, Baiocchi G
    US-guided versus US-assisted tandem insertion for cervical cancer: A nomenclature proposal.
    Brachytherapy. 2021 Dec 31. pii: S1538-4721(21)00534.
    PubMed    


  84. ORDI J
    [Cervical cancer screening in Spain: Historical perspective, current status, and recommendations for the future].
    Rev Esp Patol. 2022;55:1-3.
    PubMed    


  85. ZHANG HP, Huang GX, Chen QY, Zhong LL, et al
    [Primary cervical large cell neuroendocrine carcinoma with cytological features: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:71-73.
    PubMed    


  86. MEHROTRA R, Yadav K
    Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management.
    Indian J Gynecol Oncol. 2022;20:4.
    PubMed    
    Abstract available

  87. ZHANG L, Yu H, Deng T, Ling L, et al
    FNDC3B and BPGM Are Involved in Human Papillomavirus-Mediated Carcinogenesis of Cervical Cancer.
    Front Oncol. 2021;11:783868.
    PubMed    
    Abstract available

  88. MCDANIEL CC, Hallam HH, Cadwallader T, Lee HY, et al
    Persistent racial disparities in cervical cancer screening with Pap test.
    Prev Med Rep. 2021;24:101652.
    PubMed    
    Abstract available

  89. LEDER MACEK AJ, Kirschenbaum JD, Ricklan SJ, Schreiber-Stainthorp W, et al
    Validation of rule-based algorithms to determine colorectal, breast, and cervical cancer screening status using electronic health record data from an urban healthcare system in New York City.
    Prev Med Rep. 2021;24:101599.
    PubMed    
    Abstract available

  90. CEN Y, Zhu T, Zhang Y, Zhao L, et al
    hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA.
    Mol Ther Nucleic Acids. 2021;27:227-240.
    PubMed    
    Abstract available

  91. ZHENG X, Li C, Zhang L, Cao F, et al
    Combining Intravoxel Incoherent Motion Diffusion Weighted Imaging and Texture Analysis for a Nomogram to Predict Early Treatment Response to Concurrent Chemoradiotherapy in Cervical Cancer Patients.
    J Oncol. 2021;2021:9345353.
    PubMed    
    Abstract available

  92. CAI Y, Li C, Peng F, Yin S, et al
    Downregulation of hsa_circRNA_0001400 Helps to Promote Cell Apoptosis Through Disruption of the circRNA_0001400-miR-326 Sponge in Cervical Cancer Cells.
    Front Genet. 2021;12:779195.
    PubMed    
    Abstract available

  93. QIAN K, Fu D, Jiang B, Wang Y, et al
    Mechanism of Hedyotis Diffusa in the Treatment of Cervical Cancer.
    Front Pharmacol. 2021;12:808144.
    PubMed    
    Abstract available

  94. BAI R, Diao B, Li K, Xu X, et al
    Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer.
    Pathol Oncol Res. 2021;27:1610006.
    PubMed    
    Abstract available

  95. HUANG Y, Liu R, Han X, Hou X, et al
    Rab31 promotes the invasion and metastasis of cervical cancer cells by inhibiting MAPK6 degradation.
    Int J Biol Sci. 2022;18:112-123.
    PubMed    
    Abstract available

  96. SHARMA P, Yadav P, Jain RP, Bera AK, et al
    miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Life Sci. 2021;291:120268.
    PubMed    
    Abstract available

  97. VAN TRANG N, Prem K, Toh ZQ, Viet Ha BT, et al
    Prevalence and Determinants of Vaginal Infection With Human Papillomavirus Among Female University Students in Vietnam.
    In Vivo. 2022;36:241-250.
    PubMed    
    Abstract available

  98. MARKOVINA S
    The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer.
    J Gynecol Oncol. 2022;33:e20.
    PubMed    


  99. FAN LX, Tao L, Lai YC, Cai SY, et al
    Cx32 promotes autophagy and produces resistance to SNinduced apoptosis via activation of AMPK signalling in cervical cancer.
    Int J Oncol. 2022;60.
    PubMed    
    Abstract available

  100. CAI M, Yao F, Ding J, Zheng R, et al
    MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery.
    Front Oncol. 2021;11:749114.
    PubMed    
    Abstract available

  101. ZHAI Q, Zhang W, Zhang Z, Fu Y, et al
    Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity.
    Pol J Microbiol. 2021;70:489-500.
    PubMed    
    Abstract available

  102. NESSLER K, Ball F, Chan SKF, Chwalek M, et al
    Barriers and attitudes towards cervical cancer screening in primary healthcare in Poland - doctors' perspective.
    BMC Fam Pract. 2021;22:260.
    PubMed    
    Abstract available

  103. LEHTINEN M, Pimenoff VN
    Moral dilemma(s) in human papillomavirus vaccination - revisiting the role of the herd effect.
    Euro Surveill. 2021;26.
    PubMed    


  104. BASKY G
    Policy in focus: fee-for-service woes, record health spending, and earlier HPV vaccination cuts cancer risk.
    CMAJ. 2021;193:E1848-E1849.
    PubMed    


  105. SONG Y, Pan H, Yang L, Fan Y, et al
    DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
    Biochem Biophys Res Commun. 2021;585:177-184.
    PubMed    
    Abstract available

  106. LATYPOVA DK, Shmakov SV, Pechkovskaya SA, Filatov AS, et al
    Identification of Spiro-Fused Pyrrolo[3,4-a]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  107. MARKHAM A
    Tisotumab Vedotin: First Approval.
    Drugs. 2021;81:2141-2147.
    PubMed    
    Abstract available

  108. CRUICKSHANK ME, Grigore M
    Cervical cancers avoided by HPV immunisation.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02396.
    PubMed    


  109. OUH YT, Park JJ, Kang M, Kim M, et al
    Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia.
    J Obstet Gynaecol Res. 2022;48:207-214.
    PubMed    
    Abstract available

  110. SALINAS-MONTALVO AM, Supramaniam A, McMillan NA, Idris A, et al
    RNA-based gene targeting therapies for human papillomavirus driven cancers.
    Cancer Lett. 2021;523:111-120.
    PubMed    
    Abstract available

  111. CHOI S, Kim SW, Kim HS
    Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.
    Cancer Genomics Proteomics. 2021;18:685-698.
    PubMed    
    Abstract available

  112. WHITWORTH H, Changalucha J, Baisley K, Watson-Jones D, et al
    Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
    Trop Med Int Health. 2021;26:1345-1355.
    PubMed    
    Abstract available

  113. YUN P, Xia B, Tian XH, Gong T, et al
    Body composition and risk of major gynecologic malignancies: Results from the UK Biobank prospective cohort.
    Cancer Med. 2021;10:4522-4531.
    PubMed    
    Abstract available

  114. MARTINEZ-NOEL G, Vieira VC, Szajner P, Lilienthal EM, et al
    Live cell, image-based high-throughput screen to quantitate p53 stabilization and viability in human papillomavirus positive cancer cells.
    Virology. 2021;560:96-109.
    PubMed    
    Abstract available

  115. YANG H, Chen M, Mei Z, Xie C, et al
    Effectiveness and prognostic factors of apatinib treatment in patients with recurrent or advanced cervical carcinoma: A retrospective study.
    Cancer Med. 2021;10:4282-4290.
    PubMed    
    Abstract available

  116. BUTTERFIELD R, Dhanani S
    The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation.
    Immunol Invest. 2021;50:821-832.
    PubMed    
    Abstract available

  117. SHARMA A, Kaur H, De R, Srinivasan R, et al
    Knockdown of E-cadherin induces cancer stem-cell-like phenotype and drug resistance in cervical cancer cells.
    Biochem Cell Biol. 2021;99:587-595.
    PubMed    
    Abstract available

  118. ZHAO X, Zhou HB, Liu J, Xie J, et al
    Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.
    Kaohsiung J Med Sci. 2021;37:583-593.
    PubMed    
    Abstract available

  119. WEISSINGER M, Taran FA, Gatidis S, Kommoss S, et al
    Lymph node staging with a combined protocol of (18)F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma.
    J Nucl Med. 2021 Jan 28. pii: jnumed.120.255919. doi: 10.2967/jnumed.120.255919.
    PubMed    
    Abstract available

  120. LOPEZ-CAVANILLAS B, G Benitez C, Serrano M, Sendagorta E, et al
    Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
    J Obstet Gynaecol. 2021;41:1139-1144.
    PubMed    
    Abstract available

  121. TOMALCZYK A, Tomasik B, Fijuth J, Moszynska-Zielinska M, et al
    Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
    J Obstet Gynaecol. 2021;41:1116-1120.
    PubMed    
    Abstract available

  122. JEYAPAUL S, Oommen AM, Cherian AG, Marcus TA, et al
    Feasibility, uptake and real-life challenges of a rural cervical and breast cancer screening program in Vellore, Tamil Nadu, South India.
    Indian J Cancer. 2021;58:417-424.
    PubMed    
    Abstract available

  123. ZHANG Y, Wang Y, Liu Y, Yang J, et al
    A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.
    Appl Immunohistochem Mol Morphol. 2021;29:467-472.
    PubMed    
    Abstract available

  124. SMITH MA, Hall MT, Saville M, Brotherton JML, et al
    Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis.
    Cancer Epidemiol Biomarkers Prev. 2021;30:268-277.
    PubMed    
    Abstract available

  125. DAS T, Deb A, Parida S, Mondal S, et al
    LncRBase V.2: an updated resource for multispecies lncRNAs and ClinicLSNP hosting genetic variants in lncRNAs for cancer patients.
    RNA Biol. 2021;18:1136-1151.
    PubMed    
    Abstract available

  126. ZOU T, Dave S, Adler RN, Manning MJ, et al
    Colposcopic endocervical brushing cytology appears to be more sensitive than histologic endocervical curettage for detecting endocervical adenocarcinoma.
    J Am Soc Cytopathol. 2021;10:135-140.
    PubMed    
    Abstract available

  127. VASILYEVA D, Tiscornia-Wasserman P, Gonzalez AA
    Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology.
    J Am Soc Cytopathol. 2021;10:128-134.
    PubMed    
    Abstract available

  128. TOROUS VF, Pitman MB
    Interpretation pitfalls and malignant mimics in cervical cytology.
    J Am Soc Cytopathol. 2021;10:115-127.
    PubMed    
    Abstract available

  129. DU Y, Chen Z, Duan X, Yan P, et al
    (99m)Tc-labeled peptide targeting interleukin 13 receptor alpha 2 for tumor imaging in a cervical cancer mouse model.
    Ann Nucl Med. 2022 Jan 15. pii: 10.1007/s12149-022-01715.
    PubMed    
    Abstract available

  130. NAVARRO SANTANA B, Martin Martinez A
    Regarding "Surgical Approach and Use of Uterine Manipulator Are Not Associated with LVSI in Surgery for Early-stage Cervical Cancer: Points to be displayed".
    J Minim Invasive Gynecol. 2022 Jan 11. pii: S1553-4650(22)00023.
    PubMed    


  131. ACUTI MARTELLUCCI C, Morettini M, Brotherton JM, Canfell K, et al
    Impact of a human papillomavirus vaccination programme within organized cervical cancer screening: cohort study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-0895.
    PubMed    
    Abstract available

  132. MASSAD LS
    Impacts of the COVID-19 pandemic on cervical cancer will be severe.
    BJOG. 2022 Jan 13. doi: 10.1111/1471-0528.17100.
    PubMed    


  133. LABAN M, El-Swaify ST, Farrag N
    The Feasibility of Large Conization as a Fertility-Sparing Treatment in Young Women with Early-Stage Cervical Cancer.
    Reprod Sci. 2022 Jan 13. pii: 10.1007/s43032-021-00838.
    PubMed    
    Abstract available

  134. PORTNOY A, Nygard M, Trogstad L, Kim JJ, et al
    Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway.
    MDM Policy Pract. 2022;7:23814683211071093.
    PubMed    
    Abstract available

  135. SHIN HS, Chi E, Han HR
    [Validity and Reliability of the Korean Version of Assessment of Health Literacy in Breast and Cervical Cancer Screening].
    J Korean Acad Nurs. 2021;51:769-781.
    PubMed    
    Abstract available

  136. LAURA FC, Lucely CP, Tatiana GC, Roberto JL, et al
    Handgrip Strength, Overhydration and Nutritional Status as a Predictors of Gastrointestinal Toxicity in Cervical Cancer Patients. A Prospective Study.
    Nutr Cancer. 2022 Jan 13:1-7. doi: 10.1080/01635581.2021.2012209.
    PubMed    
    Abstract available

  137. CHI X, Gu X, Chen S, Shen X, et al
    Circ_0003221 Downregulation Restrains Cervical Cancer Cell Growth, Metastasis and Angiogenesis by Governing the miR-139-3p/S100A14 Pathway.
    Reprod Sci. 2022 Jan 13. pii: 10.1007/s43032-021-00815.
    PubMed    
    Abstract available

  138. WANG S, Luke CJ, Pak SC, Shi V, et al
    SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation.
    Commun Biol. 2022;5:46.
    PubMed    
    Abstract available

  139. GHOSH S, Jayaram P, Kabekkodu SP, Satyamoorthy K, et al
    Targeted drug delivery in cervical cancer: Current perspectives.
    Eur J Pharmacol. 2022;917:174751.
    PubMed    
    Abstract available

  140. SHAJAHAN AHAMED M, Degu A
    Health-related quality of life among cervical cancer patients at Kenyatta National Hospital.
    J Oncol Pharm Pract. 2022 Jan 12:10781552211073886.
    PubMed    
    Abstract available

  141. LI Y, Ren J, Yang JJ, Cao Y, et al
    MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
    Eur Radiol. 2022 Jan 11. pii: 10.1007/s00330-021-08463.
    PubMed    
    Abstract available

  142. SAHA S, Priya SM, Surender A, Jacob RC, et al
    Screening practices for breast and cervical cancer and associated factors, among rural women in Vellore, Tamil Nadu.
    Indian J Cancer. 2021 Sep 19. pii: 326251. doi: 10.4103.
    PubMed    
    Abstract available

  143. ZHU Y, Ren C, Yang L, Zhang Z, et al
    Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis.
    Cancer Cell Int. 2022;22:17.
    PubMed    
    Abstract available

  144. WANG Y, Yang L, Fan C, Mu H, et al
    miR-130b Expression Level Changes Promote Cervical Cancer Cell Proliferation But Inhibit its Apoptosis by Targeting CDKN1A Gene.
    Curr Cancer Drug Targets. 2022 Jan 11. pii: CCDT-EPUB-120076.
    PubMed    
    Abstract available

  145. MIYOSHI A, Ueda Y, Yagi A, Kimura T, et al
    Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.
    Hum Vaccin Immunother. 2021;17:4418-4422.
    PubMed    
    Abstract available

  146. ZHANG P, Zhao F, Jia K, Liu X, et al
    The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Bioengineered. 2022;13:2567-2584.
    PubMed    
    Abstract available

  147. DAVIES J, Spencer A, Macdonald S, Dobson L, et al
    Cervical cancer and COVID: an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study.
    BJOG. 2022 Jan 11. doi: 10.1111/1471-0528.17098.
    PubMed    
    Abstract available

  148. SAITOH E, Saika K, Morisada T, Aoki D, et al
    Status of cervical cancer screening among adolescents and young adults (AYA) in Japan.
    Int J Clin Oncol. 2022 Jan 11. pii: 10.1007/s10147-021-02100.
    PubMed    
    Abstract available

  149. DONG A, Xu B, Wang Z, Miao X, et al
    Survivalrelated DLEU1 is associated with HPV infection status and serves as a biomarker in HPVinfected cervical cancer.
    Mol Med Rep. 2022;25.
    PubMed    
    Abstract available

  150. DE LA FUENTE-HERNANDEZ MA, Alanis-Manriquez EC, Ferat-Osorio E, Rodriguez-Gonzalez A, et al
    Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells.
    Cell Oncol (Dordr). 2022 Jan 11. pii: 10.1007/s13402-021-00653.
    PubMed    
    Abstract available

  151. LI J, Liu H, Li Y, Li J, et al
    Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
    Trials. 2022;23:29.
    PubMed    
    Abstract available

  152. LIU Y, Chen J, Zhou L, Yin C, et al
    LINC00885 promotes cervical cancer progression through sponging miR-3150b-3p and upregulating BAZ2A.
    Biol Direct. 2022;17:4.
    PubMed    
    Abstract available

  153. CHEN W, Xiu S, Xie X, Guo H, et al
    Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.
    Radiat Oncol. 2022;17:6.
    PubMed    
    Abstract available

  154. YANG JI, Lee HL, Choi SH, Kim J, et al
    Reactive Oxygen Species-Sensitive Nanophotosensitizers of Methoxy Poly(ethylene glycol)-Chlorin e6/Phenyl Boronic Acid Pinacol Ester Conjugates Having Diselenide Linkages for Photodynamic Therapy of Cervical Cancer Cells.
    Materials (Basel). 2021;15.
    PubMed    
    Abstract available

  155. CHEN YF, Shen MR
    The Important Role of Ion Transport System in Cervical Cancer.
    Int J Mol Sci. 2021;23.
    PubMed    
    Abstract available

  156. OIKE T, Sekiguchi Y, Yoshimoto Y, Oike T, et al
    Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.
    Int J Mol Sci. 2021;23.
    PubMed    
    Abstract available

  157. JEONG SY, Park BK, Choi CH, Lee YY, et al
    Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  158. TANTARI M, Bogliolo S, Morotti M, Balaya V, et al
    Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  159. DU S, Qian J, Tan S, Li W, et al
    Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.
    Cancer Lett. 2022;529:168-179.
    PubMed    
    Abstract available

  160. BASAK M, Mitra S, Agnihotri SK, Jain A, et al
    Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test.
    ACS Appl Bio Mater. 2021;4:5378-5390.
    PubMed    
    Abstract available

  161. SIMON AT, Dutta D, Chattopadhyay A, Ghosh SS, et al
    Quercetin-Loaded Luminescent Hydroxyapatite Nanoparticles for Theranostic Application in Monolayer and Spheroid Cultures of Cervical Cancer Cell Line In Vitro.
    ACS Appl Bio Mater. 2021;4:4495-4506.
    PubMed    
    Abstract available

  162. LI YT, Lee WL, Wang PH
    Neurogenic bladder in patients with cervical cancer after treatment.
    J Chin Med Assoc. 2022;85:1-2.
    PubMed    


  163. MEHMOOD M, Rizwan M, Gregus Ml M, Abbas S, et al
    Machine Learning Assisted Cervical Cancer Detection.
    Front Public Health. 2021;9:788376.
    PubMed    
    Abstract available

  164. WAN T, Cai G, Gao S, Feng Y, et al
    Preoperative Evaluation of Perineural Invasion in Cervical Cancer: Development and Independent Validation of a Novel Predictive Nomogram.
    Front Oncol. 2021;11:774459.
    PubMed    
    Abstract available

  165. LEE YJ, Lee IJ, Park S, Kim TS, et al
    Transvaginal lymphatic embolization of the fistula between a pelvic lymphocele and the vaginal stump following radical hysterectomy and sentinel pelvic lymph node biopsy in a patient with cervical cancer: A case report.
    Mol Clin Oncol. 2022;16:49.
    PubMed    
    Abstract available

  166. JOSEPH NT, Namuli A, Kakuhikire B, Baguma C, et al
    Implementing community-based human papillomavirus self-sampling with SMS text follow-up for cervical cancer screening in rural, southwestern Uganda.
    J Glob Health. 2021;11:04036.
    PubMed    
    Abstract available

  167. MENG H, Zhang Y, Chen Y
    Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction.
    Evid Based Complement Alternat Med. 2021;2021:4355805.
    PubMed    
    Abstract available

  168. ORTIZ-GUTIERREZ F, Sanchez-Minutti L, Martinez-Herrera JF, Torres-Escobar ID, et al
    Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer.
    Pol J Microbiol. 2021;70:501-509.
    PubMed    
    Abstract available

  169. FU M, Pei Y, Lu F, Jiang H, et al
    Identification of Potential Hub Genes and miRNA-mRNA Pairs Related to the Progression and Prognosis of Cervical Cancer Through Integrated Bioinformatics Analysis.
    Front Genet. 2021;12:775006.
    PubMed    
    Abstract available

  170. HU C, Liu T, Han C, Xuan Y, et al
    HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression.
    Int J Biol Sci. 2022;18:507-521.
    PubMed    
    Abstract available

  171. HERMAYERNI SIMANULLANG R, Cahaya Situmorang P, Herlina M, Noradina, et al
    Cytochrome c Expression by Andaliman (Zanthoxylum acanthopodium) on Cervical Cancer Histology.
    Pak J Biol Sci. 2022;25:49-55.
    PubMed    
    Abstract available

  172. WANG Y, Chen X, Pu H, Yuan Y, et al
    Roles of DWI and T2-weighted MRI volumetry in the evaluation of lymph node metastasis and lymphovascular invasion of stage IB-IIA cervical cancer.
    Clin Radiol. 2022 Jan 6. pii: S0009-9260(21)00593.
    PubMed    
    Abstract available

  173. ZHU L, Chen J, Yan T, Alimu G, et al
    Corrigendum: Near-infrared emissive polymer-coated IR-820 nanoparticles assisted photothermal therapy for cervical cancer cells.
    J Biophotonics. 2022 Jan 9:e202200004. doi: 10.1002/jbio.202200004.
    PubMed    


  174. LI J, Wang H
    H3K27ac-activated EGFR-AS1 promotes cell growth in cervical cancer through ACTN4-mediated WNT pathway.
    Biol Direct. 2022;17:3.
    PubMed    
    Abstract available

  175. WORSHAM CM, Woo J, Zimerman A, Bray CF, et al
    Association of Maternal Cervical Disease With Human Papillomavirus Vaccination Among Offspring.
    JAMA Netw Open. 2021;4:e2134566.
    PubMed    
    Abstract available

  176. CHAND V, Kapoor A, Kundu S, Nag A, et al
    Identification of a peptide that disrupts hADA3-E6 interaction with implications in HPV induced cancer therapy.
    Life Sci. 2022;288:120157.
    PubMed    
    Abstract available

  177. TAGNE SIMO R, Djoko Nono AG, Fogang Dongmo HP, Seke Etet PF, et al
    Prevalence of precancerous cervical lesions and high-risk human papillomavirus types in Yaounde, Cameroon.
    J Infect Dev Ctries. 2021;15:1339-1345.
    PubMed    
    Abstract available

  178. ZHANG Q, Zong L, Zhang H, Xie W, et al
    B7-H4 Expression in Precancerous Lesions of the Uterine Cervix.
    Biomed Res Int. 2021;2021:5857092.
    PubMed    
    Abstract available

  179. CARR-LOPEZ SM, Strohecker L, Miyahara R, Mai Y, et al
    The addition of women's health initiatives to an established remote population health introductory pharmacy practice experience.
    J Am Pharm Assoc (2003). 2022;62:357-362.
    PubMed    
    Abstract available

  180. REN H, Almadani N, Pors J, Leung S, et al
    International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
    Int J Gynecol Pathol. 2021;40:533-540.
    PubMed    
    Abstract available

  181. DZOBO K
    What to Do for Increasing Cancer Burden on the African Continent? Accelerating Public Health Diagnostics Innovation for Prevention and Early Intervention on Cancers.
    OMICS. 2021;25:567-579.
    PubMed    
    Abstract available

  182. RADOMSKA A, Lee D, Neufeld H, Korte N, et al
    A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Diagn Pathol. 2021;16:68.
    PubMed    
    Abstract available

  183. SUAREZ NA, Peitzmeier SM, Potter J, Samandur A, et al
    Preliminary findings for adverse childhood experiences and associations with negative physical and mental health and victimization in transmasculine adults.
    Child Abuse Negl. 2021;118:105161.
    PubMed    
    Abstract available

  184. WEN YL, Yan SM, Wei W, Yang X, et al
    Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
    Mol Med. 2021;27:60.
    PubMed    
    Abstract available

  185. ZHU GL, Hao Q, Xing L, Yang XQ, et al
    C21, C22 pregnane glycosides and cytotoxic C27 spriostanol steroids from Asparagus cochinchinesis.
    Steroids. 2021;172:108874.
    PubMed    
    Abstract available

  186. YIM MS, Hwang YS, Bang JK, Jung DW, et al
    Morphologically homogeneous, pH-responsive gold nanoparticles for non-invasive imaging of HeLa cancer.
    Nanomedicine. 2021;34:102394.
    PubMed    
    Abstract available

  187. PLUMMER RM, Kelting S, Madan R, O'Neil M, et al
    Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    J Am Soc Cytopathol. 2021;10:255-260.
    PubMed    
    Abstract available

  188. AITKEN CA, Jansen EEL, Siebers AG, van Haaften-de Jong ALD, et al
    Risk of Gynecologic Cancer after Atypical Glandular Cells Found on Cervical Cytology: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:743-750.
    PubMed    
    Abstract available

  189. CADMAN L, Reuter C, Jitlal M, Kleeman M, et al
    A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1.
    Cancer Epidemiol Biomarkers Prev. 2021;30:661-668.
    PubMed    
    Abstract available

  190. ABU-SINN D, Jamison J, Evans M, McCluggage WG, et al
    Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma.
    Int J Gynecol Pathol. 2021;40:541-548.
    PubMed    
    Abstract available

  191. BARQUET-MUNOZ SA, Pedroza-Torres A, Perez-Plasencia C, Montano S, et al
    microRNA Profile Associated with Positive Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Curr Oncol. 2022;29:243-254.
    PubMed    
    Abstract available

  192. DANAN ER, Brunner J, Bergman A, Spoont M, et al
    The Relationship Between Sexual Assault History and Cervical Cancer Screening Completion Among Women Veterans in the Veterans Health Administration.
    J Womens Health (Larchmt). 2022 Jan 18. doi: 10.1089/jwh.2021.0237.
    PubMed    
    Abstract available

  193. JIANG L, Wang X
    The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.
    Bioengineered. 2022;13:3323-3332.
    PubMed    
    Abstract available

  194. KOMERSKA K, Macios A, Glinska P, Olszewski W, et al
    Why are Polish women diagnosed with invasive cervical cancer after negative cytology in the organized screening programme - a pilot reevaluation of negative Pap smears preceding diagnoses of interval cancers.
    Pol J Pathol. 2021;72:261-266.
    PubMed    
    Abstract available

  195. WOJDAT R, Malanowska E
    Retrospective Analysis of Cervical Cancer Treatment Outcomes: Ten Years of Experience with the Vaginal Assisted Radical Laparoscopic Hysterectomy VARLH.
    Biomed Res Int. 2022;2022:5163886.
    PubMed    
    Abstract available

  196. MACCHIA G, Ferrandina G, Patarnello S, Autorino R, et al
    Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept.
    Front Oncol. 2022;11:797454.
    PubMed    
    Abstract available

  197. SAFI S, Badshah Y, Shabbir M, Zahra K, et al
    Predicting 3D Structure, Cross Talks, and Prognostic Significance of KLF9 in Cervical Cancer.
    Front Oncol. 2022;11:797007.
    PubMed    
    Abstract available

  198. VALIYAVEETTIL D, Jilla S, Krishna JM, Kollu R, et al
    Cisplatin induced cerebral sinus venous thrombosis in cervical cancer patients treated with concurrent chemoradiation: a case series.
    Ecancermedicalscience. 2021;15:1320.
    PubMed    
    Abstract available

  199. YANG J, Wang Y, Zhang S, Li Y, et al
    The Association of TNF-alpha Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population.
    Int J Gen Med. 2022;15:417-427.
    PubMed    
    Abstract available

  200. GORDHANDAS SB, Manning-Geist B, Henson C, Iyer G, et al
    Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.
    Sci Rep. 2022;12:974.
    PubMed    
    Abstract available

  201. MIYAZAWA M, Ozaki D, Murata K, Habano Y, et al
    [Usefulness of Metal Artifact-reduced Reconstruction for Image-guided Brachytherapy for Cervical Cancer].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2022;78:72-80.
    PubMed    
    Abstract available

  202. VATS A, Skrabar N, Del Sal G, Banks L, et al
    Loss of the E6AP ubiquitin ligase induces p53-dependent phosphorylation of HPV-18 E6 in cells derived from cervical cancer.
    J Virol. 2022 Jan 19:JVI0150321. doi: 10.1128/JVI.01503.
    PubMed    
    Abstract available

  203. SONG Q, Wen J, Li W, Xue J, et al
    HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6 mediated CD147 polyubiquitination.
    Cancer Sci. 2022 Jan 18. doi: 10.1111/cas.15269.
    PubMed    
    Abstract available

  204. ZHANG H, Kong W, Zhao X, Han C, et al
    N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    BMC Genom Data. 2022;23:8.
    PubMed    
    Abstract available

  205. CHOI JY, Yeob KE, Hong SH, Kim SY, et al
    Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities.
    Cancer Control. 2021;28:10732748211055268.
    PubMed    
    Abstract available

  206. WAGNER J, Stibi S, Selak N, Alvir I, et al
    Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer.
    Wien Med Wochenschr. 2022 Jan 18. pii: 10.1007/s10354-021-00907.
    PubMed    
    Abstract available

  207. SUK R, Hong YR, Rajan SS, Xie Z, et al
    Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
    JAMA Netw Open. 2022;5:e2143582.
    PubMed    
    Abstract available

  208. MURAKAMI N, Kuno I, Yoshida H, Shiraishi K, et al
    How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
    J Radiat Res. 2022 Jan 18. pii: 6510150. doi: 10.1093.
    PubMed    
    Abstract available

  209. LI D, Hu X
    Solitary abdominal muscle metastasis of cervical cancer after surgery mimicking mesenchymal sarcoma on MRI and (18)F-FDG PET/CT imaging.
    Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Jan 14. pii: S2253-8089(21)00157.
    PubMed    


  210. ZHONG L, Tang L, He X
    Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3.
    Bioengineered. 2022;13:2971-2980.
    PubMed    
    Abstract available

  211. STANKOVA VERONIKA, Pilka Radovan
    Robotic surgical staging of lymphadenectomy during pregnancy - case report.
    Ceska Gynekol. 2021;86:387-391.
    PubMed    
    Abstract available

  212. WEI Y, Wei C, Chen L, Liu N, et al
    Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation.
    Cancer Res Treat. 2022 Jan 17. pii: crt.2021.963. doi: 10.4143/crt.2021.
    PubMed    
    Abstract available

  213. CAROZZI F, Burroni E, Confortini M, Pompeo G, et al
    Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme.
    J Med Screen. 2022 Jan 17:9691413211067922. doi: 10.1177/09691413211067922.
    PubMed    
    Abstract available

  214. SANTARELLI IM, Manzella PO, Alvarez F, Ramognino V, et al
    [Malignant psoas syndrome secondary to uterine cervical carcinoma].
    Medicina (B Aires). 2022;82:142-146.
    PubMed    
    Abstract available

  215. TIAN R, Liu J, Fan W, Li R, et al
    Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells.
    Mol Ther Oncolytics. 2021;24:171-179.
    PubMed    
    Abstract available

  216. JAMORA KE, Patricia A Canal J
    Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation.
    Gynecol Oncol Rep. 2022;39:100919.
    PubMed    
    Abstract available


  217. Retraction: LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
    Front Oncol. 2021;11:840051.
    PubMed    
    Abstract available

  218. WANG P, Wang S, Zhang Y, Duan X, et al
    Multispectral Image under Tissue Classification Algorithm in Screening of Cervical Cancer.
    J Healthc Eng. 2022;2022:9048123.
    PubMed    
    Abstract available

  219. ZHANG H, Zhang Y
    Application of vincristine and cisplatin combined with intensity-modulated radiation therapy in the treatment of patients with advanced cervical cancer.
    Am J Transl Res. 2021;13:13894-13901.
    PubMed    
    Abstract available

  220. ZHAO Q, Liu J, Wang S, Wang X, et al
    The Clinical Efficacy of Chemotherapy Combined with Traditional Chinese Medicine in the Treatment of Cervical Cancer and Its Influence on Cellular Immunity, Serum CEA, and TNF-alpha.
    Evid Based Complement Alternat Med. 2022;2022:7728739.
    PubMed    
    Abstract available

  221. TORRES-ROMAN JS, Ronceros-Cardenas L, Valcarcel B, Bazalar-Palacios J, et al
    Cervical cancer mortality among young women in Latin America and the Caribbean: trend analysis from 1997 to 2030.
    BMC Public Health. 2022;22:113.
    PubMed    
    Abstract available

  222. ATCI MM, Akagunduz B, Demir M, Donmez Yilmaz B, et al
    Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated With Concurrent Chemoradiation: A Multicenter Study.
    Oncol Res Treat. 2022 Jan 14. pii: 000521980. doi: 10.1159/000521980.
    PubMed    
    Abstract available

  223. CHEN L, Li H, Yao D, Zou Q, et al
    The novel circ_0084904/miR-802/MAL2 axis promotes the development of cervical cancer.
    Reprod Biol. 2022;22:100600.
    PubMed    
    Abstract available

  224. WEI J, Gao Y, Li Z, Jia H, et al
    LncRNA SNHG6 facilitates cell proliferation, migration, invasion and EMT by upregulating UCK2 and activating the Wnt/beta-catenin signaling in cervical cancer.
    Bioorg Chem. 2021;120:105488.
    PubMed    
    Abstract available

  225. VONKA V, Hirsch I
    Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility?
    Cent Eur J Public Health. 2021;29:247-258.
    PubMed    
    Abstract available

  226. DEMA E, Gibbs J, Clifton S, Copas AJ, et al
    Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID).
    Lancet Public Health. 2022;7:e36-e47.
    PubMed    
    Abstract available

  227. MOKOALA KMG, Lawal IO, Jeong JM, Sathekge MM, et al
    Radionuclide imaging of hypoxia: Where are we now? Special attention to cancer of the cervix uteri.
    Hell J Nucl Med. 2021;24:247-261.
    PubMed    
    Abstract available

  228. BARILLARI G, Bei R, Manzari V, Modesti A, et al
    Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  229. ZHANG J, Tian X, Chen Y, Huang S, et al
    Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing.
    JAMA Netw Open. 2021;4:e2140644.
    PubMed    
    Abstract available

  230. GAO FF, Quan JH, Lee MA, Ye W, et al
    Trichomonas vaginalis induces apoptosis via ROS and ER stress response through ER-mitochondria crosstalk in SiHa cells.
    Parasit Vectors. 2021;14:603.
    PubMed    
    Abstract available

  231. COLON-LOPEZ V, Ayala-Marin A, Velez-Alamo C, Soto-Salgado M, et al
    inverted exclamation markHabla de VPH! An Educational Activity for College Students in Puerto Rico.
    P R Health Sci J. 2021;40:142-146.
    PubMed    
    Abstract available

  232. LOBO SJ, Lin JG, Vais S, Wang D, et al
    Pap Smear and Mammogram Screening Rates in a Refugee and General OB/GYN Clinic: A Retrospective Review.
    J Immigr Minor Health. 2022;24:111-117.
    PubMed    
    Abstract available

  233. DEBERNARDI A, Jarassier W, Soret C, Mougin C, et al
    Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.
    Arch Virol. 2021;166:3421-3425.
    PubMed    
    Abstract available

  234. WIJAYA ST, Ngoi NY, Tan DS
    The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers.
    Best Pract Res Clin Obstet Gynaecol. 2022;78:14-35.
    PubMed    
    Abstract available

  235. ANAND KV, Pimple SA, Bhattacharjee A, Mishra GA, et al
    Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
    Asian Pac J Cancer Prev. 2021;22:2709-2716.
    PubMed    
    Abstract available

  236. BHATLA N, Tomar S, Meena J, Sharma DN, et al
    Adjuvant treatment in cervical, vaginal and vulvar cancer.
    Best Pract Res Clin Obstet Gynaecol. 2022;78:36-51.
    PubMed    
    Abstract available

  237. KOZUBIK E, Pribulova T, Rokos T, Kudela E, et al
    Comedo-like skin metastases in cervical carcinoma.
    Neuro Endocrinol Lett. 2021;42:157-159.
    PubMed    
    Abstract available

  238. GONG J, Jiang J, Qu J, Li J, et al
    Association between the rs3733846 in the flanking region of miR-143/145 and risk of cervical squamous cell carcinoma.
    Biomark Med. 2021;15:891-897.
    PubMed    
    Abstract available

  239. ROSALIK K, Tarney C, Han J
    Human Papilloma Virus Vaccination.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  240. YADAV R, Zhai L, Kunda NK, Muttil P, et al
    Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  241. CARVALHO J, Lopes-Nunes J, Vialet B, Rosado T, et al
    Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
    Nanomedicine. 2021;36:102429.
    PubMed    
    Abstract available

  242. GANDHI S, Nor Rashid N, Mohamad Razif MF, Othman S, et al
    Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Mol Biol Rep. 2021;48:5121-5133.
    PubMed    
    Abstract available

  243. MIRZADEH N, Telukutla SR, Luwor R, Priver S, et al
    Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism.
    Metallomics. 2021;13.
    PubMed    
    Abstract available

  244. GOYAL A, Davey DD, Souers RJ, Tabbara SO, et al
    Rescreening Practices of Negative Papanicolaou Tests With Positive Human Papillomavirus Test Result.
    Arch Pathol Lab Med. 2022;146:78-83.
    PubMed    
    Abstract available

  245. MUNKHDELGER J, Shimooka T, Koyama Y, Ikeda S, et al
    Basaloid Squamous Cell Carcinoma of the Uterine Cervix: Report of a Case With Molecular Analysis.
    Int J Surg Pathol. 2021;29:770-774.
    PubMed    
    Abstract available

  246. LI A, Li J, Austin RM, Wang T, et al
    Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
    Cancer Cytopathol. 2021;129:622-631.
    PubMed    
    Abstract available

  247. PELLOM ST, Smalley Rumfield C, Morillon YM 2nd, Roller N, et al
    Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009.
    JCI Insight. 2021;6.
    PubMed    
    Abstract available

  248. IWASAKI H, Shimura T, Kataoka H
    Milky Ascites With Severe Peritonitis.
    Gastroenterology. 2021;161:e4-e5.
    PubMed    


  249. ARANGO BRAVO E, Carmona T, Castro-Eguiluz D, Gallardo-Rincon D, et al
    Treatment of Locally Advanced Cervical Cancer With Kidney Failure and Comorbidities.
    Oncology (Williston Park). 2021;35:741-745.
    PubMed    
    Abstract available

  250. SHAFABAKHSH R, Reiter RJ, Aschner M, Mirzaei H, et al
    Resveratrol and Cervical Cancer: A New Therapeutic Option?
    Mini Rev Med Chem. 2022 Jan 28. pii: MRMC-EPUB-120537.
    PubMed    
    Abstract available

  251. DE GEUS V, Ewing-Graham PC, de Koning W, de Koning MNC, et al
    Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis.
    Front Oncol. 2022;11:715077.
    PubMed    
    Abstract available

  252. TAWE L, Choga WT, Paganotti GM, Bareng OT, et al
    Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya.
    BMC Infect Dis. 2022;22:95.
    PubMed    
    Abstract available

  253. CHOW B, Warkentin B, Nanda K, Ghosh S, et al
    BAIRDA: a novel in vitro setup to quantify radiobiological parameters for cervical cancer brachytherapy dose estimations.
    Phys Med Biol. 2022 Jan 27. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  254. KARISANI N, Aminimoghaddam S, Kashanian M, Baradaran HR, et al
    Diagnostic accuracy for alternative cervical cancer screening strategies: A systematic review and meta-analysis.
    Health Care Women Int. 2022 Jan 27:1-40. doi: 10.1080/07399332.2021.1998059.
    PubMed    
    Abstract available

  255. HE S, Feng Y, Zou W, Wang J, et al
    The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin.
    Front Oncol. 2022;11:784525.
    PubMed    
    Abstract available


  256. Erratum: Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer [Corrigendum].
    Int J Nanomedicine. 2022;17:245-246.
    PubMed    
    Abstract available

  257. COMPAORE ZC, Monnet E, Gerazime A, Molinie F, et al
    To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.
    Cancer Causes Control. 2022 Jan 26. pii: 10.1007/s10552-021-01536.
    PubMed    
    Abstract available

  258. TAKAGAWA Y, Izumi S, Okano T, Takahashi E, et al
    External Urethral Orifice Metastasis of Cervical Cancer Treated With Intraluminal Urethral Brachytherapy Using a Lumencath Applicator: The First Case Report.
    Adv Radiat Oncol. 2021;7:100828.
    PubMed    


  259. MAMADY K, Chen X, Malick B, Fang Z, et al
    Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer.
    J Contemp Brachytherapy. 2021;13:633-640.
    PubMed    
    Abstract available

  260. PASHA T, Hassan HN, Radhakrishna N, N MS, et al
    Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2021;13:627-632.
    PubMed    
    Abstract available

  261. FENG CH, McDaniels-Davidson C, Martinez ME, Nodora J, et al
    Brachytherapy utilization for cervical cancer in Western United States border counties: seeking to understand referral patterns for outcome improvement.
    J Contemp Brachytherapy. 2021;13:620-626.
    PubMed    
    Abstract available

  262. KAZMIERCZAK K, Cholewinski W, Nowakowski B
    Coexistence of a ruptured ectopic pregnancy and cervical cancer: how to avoid a diagnostic error when the same symptoms present two different diagnoses.
    Contemp Oncol (Pozn). 2021;25:295-297.
    PubMed    
    Abstract available

  263. AZHAR S, Wyatt LC, Jokhakar V, Patel S, et al
    Associations between Spiritual Health Locus of Control, Perceived Discrimination and Breast and Cervical Cancer Screening for Muslim American Women in New York City.
    Clin Breast Cancer. 2022 Jan 1. pii: S1526-8209(21)00373.
    PubMed    
    Abstract available

  264. HOLTZMAN S, Chaoul J, Finkelstein M, Kolev V, et al
    Regional trends of minimally invasive radical hysterectomy for cervical cancer and exploration of perioperative outcomes.
    Cancer Epidemiol. 2022;77:102095.
    PubMed    
    Abstract available

  265. LEI J, Arroyo-Muhr LS, Lagheden C, Eklund C, et al
    Human Papillomavirus Infection Determines Prognosis in Cervical Cancer.
    J Clin Oncol. 2022 Jan 25:JCO2101930. doi: 10.1200/JCO.21.01930.
    PubMed    
    Abstract available

  266. CHEN J, Wu S, Wang J, Sha Y, et al
    Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer.
    Reprod Sci. 2022 Jan 24. pii: 10.1007/s43032-022-00855.
    PubMed    
    Abstract available

  267. GU YY, Zhou GN, Li Y, He HY, et al
    HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis.
    J Oncol. 2022;2022:8092751.
    PubMed    
    Abstract available

  268. MCDOWELL JL, Young AJ, Daucher JA, Purinton SC, et al
    Utility of routine cytology in detecting asymptomatic cervical cancer recurrence.
    J Am Soc Cytopathol. 2021 Dec 29. pii: S2213-2945(21)00283.
    PubMed    
    Abstract available

  269. SHEN X, Li M, Lei Y, Lu S, et al
    An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer.
    Hum Cell. 2022 Jan 24. pii: 10.1007/s13577-022-00679.
    PubMed    
    Abstract available

  270. PEDRAZA S, Seiffert AP, Sarandeses P, Munoz-Lopez B, et al
    The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy.
    Strahlenther Onkol. 2022 Jan 24. pii: 10.1007/s00066-022-01900.
    PubMed    
    Abstract available

  271. BARUCH L, Bilitzky-Kopit A, Rosen K, Adler L, et al
    Cervical Cancer Screening Among Patients with Physical Disability.
    J Womens Health (Larchmt). 2022 Jan 20. doi: 10.1089/jwh.2021.0447.
    PubMed    
    Abstract available

  272. WIERZBA W, Jankowski M, Placiszewski K, Ciompa P, et al
    Overall survival (OS) in patients after chemotherapy for cervical cancer in Poland in years 2008-2015.
    Ginekol Pol. 2022 Jan 24. pii: VM/OJS/J/83434. doi: 10.5603/GP.a2021.0155.
    PubMed    
    Abstract available

  273. JIANG X, Wang F, Chen Y, Yan S, et al
    RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer.
    Ann Transl Med. 2021;9:1721.
    PubMed    
    Abstract available

  274. XU H, Guo C, Zhang X, Wu Y, et al
    Significance of ovarian transposition in the preservation of ovarian function for young cervical cancer patients undergoing postoperative volumetric modulated radiotherapy.
    Ann Transl Med. 2021;9:1717.
    PubMed    
    Abstract available

  275. WEN H, Guo QH, Zhou XL, Wu XH, et al
    Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature.
    Front Oncol. 2022;11:792003.
    PubMed    
    Abstract available

  276. JI H, Li K, Xu W, Li R, et al
    Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation.
    Front Oncol. 2022;11:780387.
    PubMed    
    Abstract available

  277. TADESSE A, Tafa Segni M, Demissie HF
    Knowledge, Attitude, and Practice (KAP) toward Cervical Cancer Screening among Adama Science and Technology University Female Students, Ethiopia.
    Int J Breast Cancer. 2022;2022:2490327.
    PubMed    
    Abstract available

  278. YANG J, Yang M, Lv H, Zhou M, et al
    lncRNA SNHG15 Induced by SOX12 Promotes the Tumorigenic Properties and Chemoresistance in Cervical Cancer via the miR-4735-3p/HIF1a Pathway.
    Oxid Med Cell Longev. 2022;2022:8548461.
    PubMed    
    Abstract available

  279. LI P, Highfield PE, Lang ZQ, Kell D, et al
    Cervical Cancer Prognosis and Diagnosis Using Electrical Impedance Spectroscopy.
    J Electr Bioimpedance. 2021;12:153-162.
    PubMed    
    Abstract available

  280. MA Y, Liu J, Yang Z, Chen P, et al
    CircRNA_400029 promotes the aggressive behaviors of cervical cancer by regulation of miR-1285-3p/TLN1 axis.
    J Cancer. 2022;13:541-553.
    PubMed    
    Abstract available

  281. VALLE-MENDIOLA A, Bustos-Rodriguez R, Dominguez-Melendez V, Zerecero-Carreon O, et al
    Mutations in the helix alphaC of the catalytic domain from the EGFR affect its activity in cervical cancer cell lines.
    Oncol Lett. 2022;23:71.
    PubMed    
    Abstract available

  282. REN J, Cai J, Wang C
    Tetramethylpyrazine inhibits the proliferation, invasiveness and migration of cervical cancer C33A cells by retarding the Hedgehog signaling pathway.
    Oncol Lett. 2022;23:66.
    PubMed    
    Abstract available

  283. HUANG N, Wei Y, Cheng Y, Wang X, et al
    Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
    Genes Genomics. 2022 Jan 23. pii: 10.1007/s13258-021-01205.
    PubMed    
    Abstract available

  284. WANG N, Zheng Y, Zhang X, Xu SW, et al
    Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer.
    Clin Transl Oncol. 2022 Jan 23. pii: 10.1007/s12094-021-02751.
    PubMed    
    Abstract available

  285. NILSEN A, Hillestad T, Skingen VE, Aarnes EK, et al
    miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
    Mol Oncol. 2022 Jan 21. doi: 10.1002/1878-0261.13184.
    PubMed    
    Abstract available

  286. PHATAK UA, Gosavi VS, Chitale PV
    Study of 172 Cases of AIDS Associated Cancers.
    J Assoc Physicians India. 2022;70:11-12.
    PubMed    
    Abstract available

  287. AKHATOVA A, Chan CK, Azizan A, Aimagambetova G, et al
    The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review.
    Vaccines (Basel). 2021;10.
    PubMed    
    Abstract available

  288. SUN S, Cai J, Li R, Wang Y, et al
    A meta-analysis of survival after minimally invasive radical hysterectomy versus abdominal radical hysterectomy in cervical cancer: center-associated factors matter.
    Arch Gynecol Obstet. 2022 Jan 21. pii: 10.1007/s00404-021-06348.
    PubMed    
    Abstract available

  289. LEE DH, Joo JK, Suh DS, Shin BS, et al
    Successful treatment of locally advanced bulky cervical cancer complicated by irreducible complete uterine prolapse: A case report.
    Medicine (Baltimore). 2022;101:e28664.
    PubMed    
    Abstract available

  290. MOHAMED ML, Tawfik AM, Mohammed GF, Elotla SF, et al
    Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.
    Matern Child Health J. 2022 Jan 21. pii: 10.1007/s10995-021-03352.
    PubMed    
    Abstract available

  291. KAHRAMAN S, Erbas UE, Yalcin B
    Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?
    Med Oncol. 2022;39:33.
    PubMed    
    Abstract available

  292. VOJTISEK R, Hosek P, Sukovska E, Kovarova P, et al
    Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences.
    Strahlenther Onkol. 2022 Jan 21. pii: 10.1007/s00066-021-01887.
    PubMed    
    Abstract available

  293. RAHIMY E, von Eyben R, Lewis J, Hristov D, et al
    Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy.
    Strahlenther Onkol. 2022 Jan 21. pii: 10.1007/s00066-021-01885.
    PubMed    
    Abstract available

  294. ZHAO K, Ma Z, Zhang W
    Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical Cancer.
    Front Genet. 2022;12:732822.
    PubMed    
    Abstract available

  295. ZHAO K, Yi Y, Ma Z, Zhang W, et al
    INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer.
    Front Genet. 2022;12:705512.
    PubMed    
    Abstract available

  296. WU L, Shen B, Li J, Zhang H, et al
    STAT3 exerts pro-tumor and anti-autophagy roles in cervical cancer.
    Diagn Pathol. 2022;17:13.
    PubMed    
    Abstract available

  297. FURTUNESCU F, Bohiltea RE, Neacsu A, Grigoriu C, et al
    Cervical Cancer Mortality in Romania: Trends, Regional and Rural-Urban Inequalities, and Policy Implications.
    Medicina (Kaunas). 2021;58.
    PubMed    
    Abstract available

  298. KRAKOWIAK A, Czernek L, Pichlak M, Kaczmarek R, et al
    Intracellular HINT1-Assisted Hydrolysis of Nucleoside 5'-O-Selenophosphate Leads to the Release of Hydrogen Selenide That Exhibits Toxic Effects in Human Cervical Cancer Cells.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  299. SCHMIDT MW, Battista MJ, Schmidt M, Garcia M, et al
    Efficacy and Safety of Immunotherapy for Cervical Cancer-A Systematic Review of Clinical Trials.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  300. SHIN HY, Park B, Suh M, Choi KS, et al
    Association of Late Marriage and Low Childbirth with Cervical Cancer Screening among Korean Women: Results from a Nationwide Survey.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  301. STANCA M, Capilna DM, Trambitas C, Capilna ME, et al
    The Overall Quality of Life and Oncological Outcomes Following Radical Hysterectomy in Cervical Cancer Survivors Results from a Large Long-Term Single-Institution Study.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  302. ZHANG X, Yang S, Chen W, Dong X, et al
    Circular RNA circYPEL2: A Novel Biomarker in Cervical Cancer.
    Genes (Basel). 2021;13.
    PubMed    
    Abstract available

  303. LAKKIS NA, Osman MH, Abdallah RM
    Cervix Uteri Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World.
    Cancer Control. 2022;29:10732748211068634.
    PubMed    
    Abstract available

  304. SORMANI J, Kenfack B, Wisniak A, Moukam Datchoua A, et al
    Exploring Factors Associated with Patients Who Prefer Clinician-Sampling to HPV Self-Sampling: A Study Conducted in a Low-Resource Setting.
    Int J Environ Res Public Health. 2021;19.
    PubMed    
    Abstract available

  305. JO S, Han SY, Walters CA
    Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review.
    Int J Environ Res Public Health. 2021;19.
    PubMed    
    Abstract available

  306. ILYAS S, Simanullang RH, Hutahaean S, Rosidah R, et al
    Suppression of Wnt Expression by Increasing PI3K in Rats Cervical Carcinoma by Andaliman (Zanthoxylum acanthopodium).
    Pak J Biol Sci. 2022;25:29-36.
    PubMed    
    Abstract available

  307. BAY JO, Bouleuc C, Firmin N, Gandemer V, et al
    [A 2021 inventory in oncology news].
    Bull Cancer. 2022;109:8-19.
    PubMed    
    Abstract available

  308. YIN M, Yang L, Wang Y
    Gastric-type endocervical adenocarcinoma with mucoepithelial metaplasia combined with a serous borderline tumor: A case report.
    Medicine (Baltimore). 2021;100:e28239.
    PubMed    
    Abstract available

  309. MCBRIDE E, Mase H, Kerrison RS, Marlow LAV, et al
    Improving postal survey response using behavioural science: a nested randomised control trial.
    BMC Med Res Methodol. 2021;21:280.
    PubMed    
    Abstract available

  310. MUNOZ-QUILES C, Lopez-Lacort M, Diez-Domingo J, Rodrigo-Casares V, et al
    Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009-2017.
    Vaccine. 2021 Dec 2. pii: S0264-410X(21)01536.
    PubMed    
    Abstract available

  311. PORRAS C, Sampson JN, Herrero R, Gail MH, et al
    Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
    Vaccine. 2021 Nov 29. pii: S0264-410X(21)01486.
    PubMed    
    Abstract available

  312. BLETSA G, Zagouri F, Amoutzias GD, Nikolaidis M, et al
    Genetic variability of the HPV16 early genes and LCR. Present and future perspectives.
    Expert Rev Mol Med. 2021;23:e19.
    PubMed    
    Abstract available

  313. LE GAC M, Koual M, Delanoy N, Perkins G, et al
    [Place of PARP inhibitors in the treatment of endometrial and cervical cancers].
    Bull Cancer. 2022;109:65-75.
    PubMed    
    Abstract available

  314. CHO HW, Shim SR, Lee JK, Hong JH, et al
    Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis.
    J Gynecol Oncol. 2022;33:e4.
    PubMed    
    Abstract available

  315. MACHIDA H, Matsuo K, Oba K, Aoki D, et al
    Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.
    J Gynecol Oncol. 2022;33:e3.
    PubMed    
    Abstract available

  316. MUZIO LL, Ballini A, Cantore S, Bottalico L, et al
    Overview of Candida albicans and Human Papillomavirus (HPV) Infection Agents and their Biomolecular Mechanisms in Promoting Oral Cancer in Pediatric Patients.
    Biomed Res Int. 2021;2021:7312611.
    PubMed    
    Abstract available

  317. PENG CC, Burke KT, Cardis MA
    Scalp metastasis as initial presentation of neuroendocrine carcinoma.
    Dermatol Online J. 2021;27.
    PubMed    
    Abstract available

  318. ENGINEER R, Chopra S, Shukla R, Mahantshetty U, et al
    Computed Tomography-Based Interstitial Brachytherapy for Recurrent Cervical Carcinoma in the Vaginal Apex.
    Clin Oncol (R Coll Radiol). 2022;34:e1-e6.
    PubMed    
    Abstract available

  319. YANG X, Li M, Peng Q, Huang J, et al
    Label-free detection of living cervical cells based on microfluidic device with terahertz spectroscopy.
    J Biophotonics. 2022;15:e202100241.
    PubMed    
    Abstract available

  320. SILVER MC, Neumann PJ, Ma S, Kim DD, et al
    Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
    PubMed    
    Abstract available

  321. WANG W, Gao X, Chen J, Liu Z, et al
    Metal stent for the ureteral stricture after surgery and/or radiation treatment for malignancy.
    BMC Urol. 2021;21:146.
    PubMed    
    Abstract available

  322. ZHAO X, Xia Y, Jin S, Wang Y, et al
    Squamous Cell Carcinoma Overlying Cervical Myoma.
    J Minim Invasive Gynecol. 2022;29:14-15.
    PubMed    


  323. BAIDOO JNE, Mukherjee S, Kashfi K, Banerjee P, et al
    A New Perspective on Cancer Therapy: Changing the Treaded Path?
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  324. ZHOU F, Zhang W, Cai H, Cao Y, et al
    Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo.
    Hum Vaccin Immunother. 2021;17:4433-4441.
    PubMed    
    Abstract available

  325. VIAS P, Angural H, Seam RK, Gupta MK, et al
    A prospective randomized trial comparing accelerated concurrent chemoradiotherapy with conventional concurrent chemoradiotherapy in locally advanced carcinoma cervix (IIA-IVA).
    J Cancer Res Ther. 2021;17:1012-1016.
    PubMed    
    Abstract available

  326. ALACAM S, Bakir A
    Human Papillomavirus Prevalence and Genotype Distribution in Cervical Swab Samples in Istanbul, Turkey.
    J Infect Dev Ctries. 2021;15:1190-1196.
    PubMed    
    Abstract available

  327. XU L, Li K, Chen X, Chen B, et al
    Next-generation sequencing assisted diagnosis of cervical metastasis in EGFR-mutated lung adenocarcinoma: A case report.
    Thorac Cancer. 2021;12:2622-2627.
    PubMed    
    Abstract available

  328. WANG X, Du T, Shi X, Wu K, et al
    Attitude and practice on human papilloma virus infection and vaccination among students from secondary occupational health school: a cross-sectional study.
    Hum Vaccin Immunother. 2021;17:4397-4405.
    PubMed    
    Abstract available

  329. SOLOVYEVA NI, Timoshenko OS, Kugaevskaya EV, Gureeva TA, et al
    Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.
    Mol Biol Rep. 2021;48:6879-6886.
    PubMed    
    Abstract available

  330. O'DONOVAN B, Mooney T, Rimmer B, Fitzpatrick P, et al
    Advancing understanding of influences on cervical screening (non)-participation among younger and older women: A qualitative study using the theoretical domains framework and the COM-B model.
    Health Expect. 2021;24:2023-2035.
    PubMed    
    Abstract available

  331. HAN G, Son H
    Environmental factors affecting mothers' decision-making about the HPV vaccination for their daughters.
    Hum Vaccin Immunother. 2021;17:4412-4417.
    PubMed    
    Abstract available

  332. BORTOLLI APR, Vieira VK, Stefanski EE, Lazarotto AK, et al
    Relationship between GSTM1 and GSTT1 polymorphisms and HPV infection: a systematic review.
    Mol Biol Rep. 2021;48:6631-6636.
    PubMed    
    Abstract available

  333. SAINZ JA, Castro L, Romo JM, Holgado A, et al
    Evaluation of Pre-malignant Lesions of the Uterine Cervix by Shear Wave Elastography: A New Diagnostic Tool.
    Ultrasound Med Biol. 2021;47:3275-3282.
    PubMed    
    Abstract available

  334. XIE Y, Su LY, Wang F, Tang HY, et al
    Awareness regarding and vaccines acceptability of human papillomavirus among parents of middle school students in Zunyi, Southwest China.
    Hum Vaccin Immunother. 2021;17:4406-4411.
    PubMed    
    Abstract available

  335. XU J, Zhang W
    Cervical adenosquamous carcinomas: A case report.
    Asian J Surg. 2021;44:1423-1424.
    PubMed    


  336. BAYRAMOGLU TEPE N, Bozgeyik E, Bozdag Z, Balat O, et al
    Identification of autophagy-associated miRNA signature for the cervical squamous cell cancer and high-grade cervical intraepithelial lesions.
    Reprod Biol. 2021;21:100536.
    PubMed    
    Abstract available

  337. JANG D, Ratnam S, Smieja M, Speicher DJ, et al
    Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media.
    Tumour Virus Res. 2021;12:200224.
    PubMed    
    Abstract available

  338. LAGSTROM S, Lovestad AH, Umu SU, Ambur OH, et al
    HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples.
    Tumour Virus Res. 2021;12:200221.
    PubMed    
    Abstract available

  339. PARK E, Kim YT, Kim S, Nam EJ, et al
    Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
    Mod Pathol. 2021;34:1738-1749.
    PubMed    
    Abstract available

  340. DAN W, Xu Y, Gu H, Gao J, et al
    Methylaervine as Potential Lead Compound Against Cervical Carcinoma: Pharmacologic Mechanism Prediction based on Network Pharmacology.
    Curr Comput Aided Drug Des. 2022;18:73-80.
    PubMed    
    Abstract available

  341. KUMAGAI K, Takanashi M, Ohno SI, Harada Y, et al
    WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7.
    Oncogene. 2021;40:3695-3706.
    PubMed    
    Abstract available

  342. TAO X, Zhang H, Wang S, Chen T, et al
    Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
    J Am Soc Cytopathol. 2021;10:391-398.
    PubMed    
    Abstract available

  343. MCHUGH P, Brennan D, Higgins MF
    Medical students' attitudes towards the teaching of cervical and ovarian cancer screening protocols in Ireland: a qualitative study.
    Ir J Med Sci. 2022;191:469-473.
    PubMed    
    Abstract available

  344. HUANG RSP, Haberberger J, Murugesan K, Danziger N, et al
    Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma.
    Mod Pathol. 2021;34:1425-1433.
    PubMed    
    Abstract available

  345. SEGURA S, Stolnicu S, Boros M, Park K, et al
    mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion Patterns.
    Appl Immunohistochem Mol Morphol. 2021;29:527-533.
    PubMed    
    Abstract available

  346. REN H, Jia M, Zhao S, Li H, et al
    Factors Correlated with the Accuracy of Colposcopy-Directed Biopsy: A Systematic Review and Meta-Analysis.
    J Invest Surg. 2022;35:284-292.
    PubMed    
    Abstract available

  347. SELENICA P, Alemar B, Matrai C, Talia KL, et al
    Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
    Mod Pathol. 2021;34:1213-1225.
    PubMed    
    Abstract available

  348. ALLEN CG, Todem D, Williams KP
    Adherence to Mammography and Pap Screening Guidelines Among Medically Underserved Women: the Role of Family Structures and Network-Level Behaviors.
    J Cancer Educ. 2021;36:1155-1162.
    PubMed    
    Abstract available

  349. KERR L, Fisher CM, Jones T
    Improving Cervical Screening in Trans and Gender-Diverse People.
    Cancer Nurs. 2022;45:37-42.
    PubMed    
    Abstract available

  350. KEEHN DC, Chamberlain RM, Tibbits M, Kahesa C, et al
    Using Key Informants to Evaluate Barriers to Education and Acceptability of the HPV Vaccine in Tanzania: Implications for Cancer Education.
    J Cancer Educ. 2021;36:1333-1340.
    PubMed    
    Abstract available

  351. HENKLE TR, Lam B, Kung YJ, Lin J, et al
    Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal Tract.
    Cancer Res. 2021;81:4560-4569.
    PubMed    
    Abstract available

  352. WILLIAMSON CW, Zamarin D, Mayadev J
    Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
    Clin Cancer Res. 2021;27:4136-4138.
    PubMed    
    Abstract available

  353. MONDINI M, Deutsch E
    (Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?
    Clin Cancer Res. 2021;27:3815-3817.
    PubMed    
    Abstract available

  354. YUCEL POLAT A, Tepeoglu M, Tunca MZ, Ayva ES, et al
    Atypical glandular cells in Papanicolaou test: Which is more important in the detection of malignancy, architectural or nuclear features?
    Cytopathology. 2021;32:344-352.
    PubMed    
    Abstract available

  355. ARCHONDAKIS S, Roma M, Kaladelfou E
    Implementation of pre-captured videos for remote diagnosis of cervical cytology specimens.
    Cytopathology. 2021;32:338-343.
    PubMed    
    Abstract available

  356. BRITO MJ, Quintas A, Sequeira P, Alves AT, et al
    Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
    Cytopathology. 2021;32:640-645.
    PubMed    
    Abstract available

  357. AGGARWAL D, Wadhwa N, Arora T, Rajaram S, et al
    Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
    Cytopathology. 2021;32:631-639.
    PubMed    
    Abstract available

  358. ELEUTERIO J JR, Surima W, Lima MAT, Bezerra JVS, et al
    Liquid-based cytology and HPV DNA test in anal specimens from women with cervical cancer.
    Diagn Cytopathol. 2021 Dec 30. doi: 10.1002/dc.24925.
    PubMed    
    Abstract available

  359. SIVAKUMAR N, Narwal A, Kumar S, Kamboj M, et al
    Application of the Bethesda system of reporting for cervical cytology to evaluate human papilloma virus induced changes in oral leukoplakia, oral squamous cell carcinoma, and oropharyngeal squamous cell carcinoma: A cytomorphological and genetic study
    Diagn Cytopathol. 2021;49:1036-1044.
    PubMed    
    Abstract available

  360. MANGA SM, Kincaid KD, Boitano TKL, Tita AT, et al
    Misoprostol and estradiol to enhance visualization of the transformation zone during cervical cancer screening: An integrative review.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:16-23.
    PubMed    
    Abstract available

  361. SAHLGREN H, Sparen P, Elfgren K, Miriam Elfstrom K, et al
    Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
    Eur J Obstet Gynecol Reprod Biol. 2022;268:68-73.
    PubMed    
    Abstract available

  362. CIBULA D, Dostalek L, Jarkovsky J, Mom CH, et al
    Post-recurrence survival in patients with cervical cancer.
    Gynecol Oncol. 2021 Dec 23. pii: S0090-8258(21)01675.
    PubMed    
    Abstract available

  363. GUANI B, Mahiou K, Crestani A, Cibula D, et al
    Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis.
    Gynecol Oncol. 2021 Dec 20. pii: S0090-8258(21)01672.
    PubMed    
    Abstract available

  364. EKDAHL L, Paraghamian S, Eoh KJ, Thumuluru KM, et al
    Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study.
    Gynecol Oncol. 2021 Dec 31. pii: S0090-8258(21)01697.
    PubMed    
    Abstract available

  365. SPONHOLTZ SE, Ezendam NPM, de Rooij BH, Parner E, et al
    SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life.
    Gynecol Oncol. 2021 Dec 29. pii: S0090-8258(21)01692.
    PubMed    
    Abstract available

  366. KIM SI, Choi BR, Kim HS, Chung HH, et al
    Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approach.
    Gynecol Oncol. 2021 Dec 27. pii: S0090-8258(21)01691.
    PubMed    
    Abstract available

  367. THELISSEN AAB, Jurgenliemk-Schulz IM, van der Leij F, Peters M, et al
    Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2021 Dec 27. pii: S0090-8258(21)01694.
    PubMed    
    Abstract available

  368. WANG Z, Guo E, Yang B, Xiao R, et al
    Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01327.
    PubMed    
    Abstract available

  369. HAESEN J, Salihi R, Van Gorp T, Van Nieuwenhuysen E, et al
    Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00522.
    PubMed    
    Abstract available

  370. CUZICK J, Du R, Adcock R, Kinney W, et al
    Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00525.
    PubMed    
    Abstract available

  371. AO M, Zheng D, Wang J, Gu X, et al
    Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia.
    Gynecol Oncol. 2021;162:584-589.
    PubMed    
    Abstract available

  372. SALVADO A, Miralpeix E, Sole-Sedeno JM, Kanjou N, et al
    Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00515.
    PubMed    
    Abstract available

  373. CHATZISTAMATIOU K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, et al
    Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Gynecol Oncol. 2021 Jun 28. pii: S0090-8258(21)00516.
    PubMed    
    Abstract available

  374. VAN KEER S, Peeters E, Vanden Broeck D, De Sutter P, et al
    Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
    Gynecol Oncol. 2021 Jun 22. pii: S0090-8258(21)00490.
    PubMed    
    Abstract available

  375. WAGAR MK, Sobecki JN, Chandereng T, Hartenbach EM, et al
    Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: Does modality matter?
    Gynecol Oncol. 2021 Jun 17. pii: S0090-8258(21)00491.
    PubMed    
    Abstract available

  376. GWACHAM NI, McKenzie ND, Fitzgerald ER, Ahmad S, et al
    Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gynecol Oncol. 2021;162:809-815.
    PubMed    
    Abstract available

  377. PEI X, Xiang L, Chen W, Jiang W, et al
    The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2021;161:779-786.
    PubMed    
    Abstract available

  378. MUSA FB, Brouwer E, Ting J, Schwartz NRM, et al
    Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.
    Gynecol Oncol. 2022 Jan 11. pii: S0090-8258(21)01696.
    PubMed    
    Abstract available

  379. AMPOFO AG, Boyes AW, Khumalo PG, Mackenzie L, et al
    Improving knowledge, attitudes, and uptake of cervical cancer prevention among female students: A systematic review and meta-analysis of school-based health education.
    Gynecol Oncol. 2022 Jan 5. pii: S0090-8258(21)01680.
    PubMed    
    Abstract available

  380. YAN L, Liu Y, Zhang J, Chen X, et al
    In vivo and in vitro study of the potential hazards of surgical smoke during cervical cancer treatment with an ultrasonic scalpel.
    Gynecol Oncol. 2022 Jan 12. pii: S0090-8258(22)00008.
    PubMed    
    Abstract available

  381. SETIAWAN D, Miranti I, Partiwi TD, Puspitasari DA, et al
    The Willingness of Cervical Cancer Screening Among Sexually Active Women in Indonesia: Lesson Learned from 2 Districts.
    Int J Gynaecol Obstet. 2022 Jan 25. doi: 10.1002/ijgo.14113.
    PubMed    
    Abstract available

  382. BIZZARRI N, Pletnev A, Razumova Z, Zalewski K, et al
    Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO).
    Int J Gynecol Cancer. 2022 Jan 6. pii: ijgc-2021-002812.
    PubMed    
    Abstract available

  383. RODRIGUES AN, de Melo AC, Calabrich AFC, Cronenberger E, et al
    Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
    Int J Gynecol Cancer. 2021 Dec 29. pii: ijgc-2021-002972.
    PubMed    
    Abstract available

  384. CHEN JH, Duan H, Yu XB, Zhao HW, et al
    Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
    Int J Gynecol Cancer. 2021;31:512-517.
    PubMed    
    Abstract available

  385. DOGAN NU, Kohler C, Pfiffer T, Plaikner A, et al
    Prospective assessment of urinary and bowel symptoms, and sexual function between laparoscopic assisted vaginal radical trachelectomy and radical hysterectomy.
    Int J Gynecol Cancer. 2021;31:484-489.
    PubMed    
    Abstract available

  386. BAIOCCHI G, Vieira M, Moretti-Marques R, Mantoan H, et al
    Uterine transposition for gynecological cancers.
    Int J Gynecol Cancer. 2021;31:442-446.
    PubMed    
    Abstract available

  387. BURBANO J, Heredia F, Sanabria D, Ardila EG, et al
    Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Int J Gynecol Cancer. 2021;31:387-398.
    PubMed    
    Abstract available

  388. STEWART K, Campbell S, Frumovitz M, Ramirez PT, et al
    Fertility considerations prior to conservative management of gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:339-344.
    PubMed    
    Abstract available

  389. MORO F, Bonanno GM, Gui B, Scambia G, et al
    Imaging modalities in fertility preservation in patients with gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:323-331.
    PubMed    
    Abstract available

  390. IJFF M, Crezee J, Oei AL, Stalpers LJA, et al
    The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review.
    Int J Gynecol Cancer. 2022 Jan 19. pii: ijgc-2021-002473.
    PubMed    
    Abstract available

  391. ILHAN Y, Tatli AM, Teker F, Onder AH, et al
    Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
    Int J Gynecol Cancer. 2022 Jan 27. pii: ijgc-2021-003165.
    PubMed    
    Abstract available

  392. DREYER G, Botha MH, Snyman LC, Visser C, et al
    Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
    Int J Gynecol Cancer. 2022 Jan 25. pii: ijgc-2021-003079.
    PubMed    
    Abstract available

  393. ODETTO D, Saadi JM, Chacon CB, Wernicke A, et al
    Uterine transposition after radical trachelectomy.
    Int J Gynecol Cancer. 2021;31:1374-1379.
    PubMed    


  394. LERAY H, Angeles MA, Daix M, Martinez A, et al
    How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion.
    Int J Gynecol Cancer. 2021;31:1382-1383.
    PubMed    


  395. HARRY V, Persad S, Barrow T, Rattan R, et al
    UK-trained specialists perform first radical trachelectomy in Trinidad and Tobago.
    Int J Gynecol Cancer. 2021;31:1486-1487.
    PubMed    


  396. NASIOUDIS D, Albright BB, Ko EM, Haggerty AF, et al
    Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2021;31:983-990.
    PubMed    
    Abstract available

  397. NASIOUDIS D, Latif NA, Giuntoli Ii RL, Haggerty AF, et al
    Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
    Int J Gynecol Cancer. 2021;31:829-834.
    PubMed    
    Abstract available

  398. DAMAST S, Chino J
    Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:414-416.
    PubMed    


  399. RAINE-BENNETT T, Gage JC, Poitras N, Chandra M, et al
    Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).
    J Clin Virol. 2021;145:105014.
    PubMed    
    Abstract available

  400. JOSEPH J, Mangwendeza P, Maparo T, Mhizha T, et al
    Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
    J Clin Virol. 2021;145:105017.
    PubMed    
    Abstract available

  401. FENDRICK AM, Dalton VK, Tilea A, Malone AM, et al
    Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019.
    Obstet Gynecol. 2022;139:113-115.
    PubMed    


  402. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed    
    Abstract available

  403. LIU L, Shi W, Xiao X, Wu X, et al
    BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP1 cells via the Rb/E2F1 pathway in cervical carcinoma.
    Oncol Rep. 2021;46.
    PubMed    
    Abstract available

  404. WESTERVELD H, Kirchheiner K, Nout RA, Tanderup K, et al
    Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: an EMBRACE-I sub-study.
    Radiother Oncol. 2022 Jan 18. pii: S0167-8140(21)09082.
    PubMed    
    Abstract available

  405. REN J, Li L, Yu B, Xu E, et al
    Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.
    BMC Cancer. 2022;22:88.
    PubMed    
    Abstract available

  406. MOSTAID MS, Mumu SB, Haque MA, Sharmin S, et al
    Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
    PLoS One. 2021;16:e0261984.
    PubMed    
    Abstract available

  407. DEMISSIE BW, Azeze GA, Asseffa NA, Lake EA, et al
    Communities' perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study.
    PLoS One. 2022;17:e0262142.
    PubMed    
    Abstract available

  408. BRUGGMANN D, Quinkert-Schmolke K, Jaque JM, Quarcoo D, et al
    Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis.
    PLoS One. 2022;17:e0261503.
    PubMed    
    Abstract available

  409. LIA M, Horn LC, Sodeikat P, Hockel M, et al
    The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis.
    PLoS One. 2022;17:e0262257.
    PubMed    
    Abstract available

  410. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
    Genome-wide host methylation profiling of anal and cervical carcinoma.
    PLoS One. 2021;16:e0260857.
    PubMed    
    Abstract available

  411. BAEDYANANDA F, Chaiwongkot A, Varadarajan S, Bhattarakosol P, et al
    HPV16 E1 dysregulated cellular genes involved in cell proliferation and host DNA damage: A possible role in cervical carcinogenesis.
    PLoS One. 2021;16:e0260841.
    PubMed    
    Abstract available

  412. BALEYDIER I, Vassilakos P, Vinals R, Wisniak A, et al
    Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    PLoS One. 2021;16:e0260776.
    PubMed    
    Abstract available

  413. HUSAIYIN S, Jiao Z, Yimamu K, Maisaidi R, et al
    ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients.
    PLoS One. 2021;16:e0260915.
    PubMed    
    Abstract available

  414. GONZALEZ A, Sanchez R, Camargo M, Soto-De Leon SC, et al
    Cervical cancer screening programme attendance and compliance predictors regarding Colombia's Amazon region.
    PLoS One. 2022;17:e0262069.
    PubMed    
    Abstract available

  415. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;